Andrew Hessel: Writing chromosomes with code

Autodesk Distinguished Researcher Andrew Hessel is a catalyst in biological technologies, helping industry, academics, and authorities better understand the changes happening in life science. Andrew is a key member of the Bio/Nano/Programmable Matter group at Autodesk Research. He is also the co-founder of the Pink Army Cooperative, the world’s first cooperative biotechnology company, which is aiming to make open source viral therapies for cancer.

FULL BIO | WEBSITE | TWITTER

Jim Olson: Tumor Paint

Jim Olson

Jim Olson is a physician scientist who cares for children with brain tumors and discovers/develops new cancer therapies. His lab's work led to five national clinical trials, of which he leads a Phase III trial. He authored the most widely used pharmacology review book. Olson is the founder of Presage Biosciences and Blaze Bioscience: The Tumor Paint Company.

LISTEN: NPR Radio "Doctors Test Tumor Paint in People" by Joe Palca (April 8, 2015) 

Gary Slutkin: Is it possible to end violence?

After spending years in Africa fighting AIDS, TB and cholera with the W.H.O., Gary Slutkin returned to Chicago and had an epiphany: the violence plaguing his hometown exhibited all the signs of an infectious disease. Learn how he’s applied epidemiological principles to reduce shootings and violent crime in inner-city Chicago neighborhoods by as much as 75%.
Read More